Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.65 |
| ▸ | CA1 | P00915 | 3/20 | 0.65 |
| ▸ | CA2 | P00918 | 3/20 | 0.65 |
| ▸ | CA7 | P43166 | 3/20 | 0.65 |
| ▸ | CA9 | Q16790 | 3/20 | 0.65 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.65 |
| ▸ | TPMT | P51580 | 3/20 | 0.61 |
| ▸ | TP53 | P04637 | 2/20 | 0.61 |
| ▸ | CA3 | P07451 | 2/20 | 0.61 |
| ▸ | CA4 | P22748 | 2/20 | 0.61 |
| ▸ | CA6 | P23280 | 2/20 | 0.61 |
| ▸ | CA5A | P35218 | 2/20 | 0.61 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | SELL | P14151 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | SELP | P16109 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26189 | 1.00 | CA12 (0.65) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1556954 | 0.96 | CA12 (0.61) | CA12CA1CA2CA7CA9 | |
| Potassium SCHEMBL30862175 | 0.96 | CA12 (0.61) | CA12CA1CA2CA7CA9 | |
| Hydrochloric Acid SCHEMBL3704383 | 0.96 | CA12 (0.61) | CA12CA1CA2CA7CA9 | |
| SCHEMBL15789102 | 0.96 | CA12 (0.61) | CA12CA1CA2CA7CA9 | |
| SCHEMBL23004950 | 0.96 | CA12 (0.61) | CA12CA1CA2CA7CA9 | |
| Hydrochloric Acid SCHEMBL297134 | 0.96 | CA12 (0.61) | CA12CA1CA2CA7CA9 | |
| Benzene SCHEMBL20211008 | 0.96 | CA12 (0.61) | CA12CA1CA2CA7CA9 | |
| SCHEMBL21590118 | 0.96 | CA12 (0.61) | CA12CA1CA2CA7CA9 | |
| Hydrochloric Acid SCHEMBL3704386 | 0.96 | CA12 (0.61) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753398-B2 | Therapeutic compounds | C4X DISCOVERY LIMITED (GB) | 2023-09-12 | — | — | US | claimed |
| US-8142917-B2 | Proton-conducting polymer membrane comprising polyazole blends and its use in fuel cells | BASF FUEL CELL GMBH (DE) | 2012-03-27 | — | — | US | claimed |
| EP-1701995-B1 | PROTON-CONDUCTING MEMBRANE AND USE THEREOF | BASF FUEL CELL RES GMBH (DE) | 2012-02-29 | — | — | EP | claimed |
| US-20110236563-A1 | METHOD FOR PRODUCING A PROTON-CONDUCTING MEMBRANE | BASF SE (DE) | 2011-09-29 | — | — | US | claimed |
| EP-1550174-B1 | PROTON-CONDUCTING MEMBRANE AND USE THEREOF | BASF FUEL CELL RES GMBH (DE) | 2011-05-11 | — | — | EP | claimed |
| US-7883818-B2 | producing a crosslinked hydrolyzed polybenzimidazole copolymer; polyelectrolytes with high conductivity over a wide temperature range, high mechanical stability; proton conductivity | BASF FUEL CELL GMBH (DE) | 2011-02-08 | — | — | US | claimed |
| EP-2270068-A1 | Protonconductuing membrane and application thereof | BASF Fuel Cell Research GmbH (DE) | 2011-01-05 | — | — | EP | claimed |
| JP-4445553-B2 | — | — | 2010-04-07 | — | — | JP | claimed |
| US-7632591-B2 | Branched multiblock polybenzimidazole-benzamide copolymer and method for preparing the same, electrolyte membrane and paste/gel prepared therefrom | LG CHEM, LTD. (KR) | 2009-12-15 | — | — | US | claimed |
| JP-2008512561-A | — | — | 2008-04-24 | — | — | JP | claimed |
| WO-2007055459-A1 | BRANCHED MULTIBLOCK POLYBENZIMIDAZOLE-BENZAMIDE COPOLYMER AND METHOD FOR PREPARING THE SAME, ELECTROLYTE MEMBRANE AND PASTE/GEL PREPARED THEREFROM | LG CHEM, LTD. (KR) | 2007-05-18 | — | — | WO | claimed |
| US-20070111075-A1 | Branched multiblock polybenzimidazole-benzamide copolymer and method for preparing the same, electrolyte membrane and paste/gel prepared therefrom | LG CHEM, LTD. (KR) | 2007-05-17 | — | — | US | claimed |
| WO-2024185617-A1 | METHOD FOR PRODUCING METAL-ORGANIC FRAMEWORK | 住友化学株式会社 | 2024-09-12 | — | — | WO | disclosed |
| WO-2024185618-A1 | METAL ORGANIC STRUCTURE | 住友化学株式会社 | 2024-09-12 | — | — | WO | disclosed |
| US-20240278208-A1 | Metal Organic Frameworks Having Node Defects And Methods Of Making The Same | EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (US) | 2024-08-22 | — | — | US | disclosed |
| WO-2023170102-A1 | ENCAPSULATED COMPOSITIONS | GIVAUDAN SA (CH) | 2023-09-14 | — | — | WO | disclosed |
| US-20070111075-A1 | Branched multiblock polybenzimidazole-benzamide copolymer and method for preparing the same, electrolyte membrane and paste/gel prepared therefrom | LG CHEM, LTD. (KR) | 2007-05-17 | — | — | US | disclosed |
| US-20020009671-A1 | Water insoluble binders; carbon black particles; infrared lasers | AGFA-GEVAERT N.V. (BE) | 2002-01-24 | — | — | US | disclosed |
| EP-1140750-A1 | CARBOXYLATES IN CATALYTIC HYDROLYSIS OF ALKYLENE OXIDES | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000035842-A1 | CARBOXYLATES IN CATALYTIC HYDROLYSIS OF ALKYLENE OXIDES | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2000-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11753398-B2 | Therapeutic compounds | HCRTR2, HCRTR1, NPY1R | CA12 2573/4885CA1 1051/4885CA2 1119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.